Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
DGI For The DIY
ABBV has been a great performer this year. Its up like $8 in the past 3 weeks. I wonder how much higher it can go?
Reply
(09-07-2017, 10:03 AM)divmenow Wrote: ABBV has been a great performer this year. Its up like $18 in the past 3 weeks. I wonder how much higher it can go?

Yeah, it seems a lot of biotech has been moving up of late, GILD has done well too.

I have ABBV right at fair value here. It's trading at a 14.5 PE on 2017 estimates, right in line with historical valuation levels.

Analysts are still projecting double-digit EPS growth going forward, which is pretty impressive to go along with a 3.2% yield.

It should also announce a new dividend increase in October, which will probably be another double-digit raise.

I already have an over-weight position, so I won't be adding, but if I didn't ABBV would still be at the top of my list among the drug stocks.
My Blog: DGIfortheDIY.com
Seeking Alpha Author Page 
Reply
BTW that was up $8 not $18 lol.

Yes they have. AMGN on a great run as well. That's my longest holding.

As we speak ABBV now over $80 a share. Woo Hoo lol
Reply




Users browsing this thread: 1 Guest(s)